Profluent Bio
Tuesday, June 04, 2024
Cell and Gene Therapy and Genome Editing
Company Presentation Theater 4
Profluent is an AI-first protein design company headquartered in Berkeley, CA. Founded in 2022, Profluent develops deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. The company is backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about Profluent’s mission to decode the language of life with AI, visit profluent.bio.
Company Website:
https://www.profluent.bio/
Lead Product in Development:
AI-designed gene editors
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Many
Company HQ City
Berkeley
Company HQ State
CA
Company HQ Country
United States
CEO/Top Company Official
Ali Madani
Development Phase of Primary Product
Discovery
Primary Speaker
.jpg)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())